{"entity":{"type":"insider","cik":"0001803794","url":"/insider/0001803794","json_url":"/insider/0001803794.json","name":"Yarema Kristin","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":4,"n_filings":2,"first":"2021-05-20","last":"2021-06-15","span_basis":"filed_date"},"name_variants":[{"name":"Yarema Kristin","source":"filing","n_filings":2,"first_seen":"2021-05-20","last_seen":"2021-06-15"}],"transactions":[{"id":4902017,"accession":"0001567619-21-012110","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001567619-21-012110","line_url":"/filing/0001567619-21-012110","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001803794","owner_name":"Yarema Kristin","owner_display_name":"Yarema Kristin","owner_url":"/insider/0001803794","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":32333.0,"shares_display":"32,333","price_per_share":14.569175146135526,"price_display":"14.57","price_state":"stated","total_value":471065.14,"total_display":"471,065.14","total_whole":"471,065","shares_owned_after":125882.0,"shares_owned_after_display":"125,882","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-14","filed_date":"2021-06-15","scope":"insider","n_lines":2},{"id":4901993,"accession":"0001567619-21-012110","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-21-012110","line_url":"/filing/0001567619-21-012110#line-1","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001803794","owner_name":"Yarema Kristin","owner_display_name":"Yarema Kristin","owner_url":"/insider/0001803794","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2021.0,"shares_display":"2,021","price_per_share":14.5,"price_display":"14.50","price_state":"stated","total_value":29304.5,"total_display":"29,304.50","total_whole":"29,305","shares_owned_after":93549.0,"shares_owned_after_display":"93,549","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-11","filed_date":"2021-06-15","scope":"insider"},{"id":5428262,"accession":"0001209191-21-034422","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-034422","line_url":"/filing/0001209191-21-034422#line-1","is_derivative":false,"issuer_cik":"0001604464","issuer_name":"Atara Biotherapeutics, Inc.","issuer_ticker":"ATRA","issuer_name_source":null,"issuer_url":"/issuer/0001604464","owner_cik":"0001803794","owner_name":"Yarema Kristin","owner_display_name":"Yarema Kristin","owner_url":"/insider/0001803794","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":761.0,"shares_display":"761","price_per_share":14.55,"price_display":"14.55","price_state":"stated","total_value":11072.55,"total_display":"11,072.55","total_whole":"11,073","shares_owned_after":91528.0,"shares_owned_after_display":"91,528","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-18","filed_date":"2021-05-20","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":4,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":3,"open_market":true},{"code":"S","label":"Open-market sale","n":1,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":4},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001604464","name":"Atara Biotherapeutics, Inc.","url":"/issuer/0001604464","role":"Officer (Chief Commercial Officer)","n_filings":2,"first_seen":"2021-05-20","last_seen":"2021-06-15"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001803794","retrieved_at":"2026-08-27T01:41:53+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}